BrunoBockornyMD

Oncology • Boston, MA

Gastrointestinal Cancer, Sarcoma

Physician

Join to view full profile

Dr. Bockorny is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bockorny's full profile

Already have an account?

Office
330 Brookline Avenue
Boston, MA 02215
Phone+1 617-667-7000

Summary

Dr. Bruno Bockorny is an oncologist in Boston, MA and is affiliated with Beth Israel Deaconess Medical Center. He received his medical degree from Federal University of Rio de Janeiro School of Medical Sience and has been in practice 13 years. He specializes in gastrointestinal cancer and sarcoma. He has more than 30 publications and over 500 citings.

Education & Training

Fed Univ Rio de Janeiro- Sch Med SciClass of 2007

Certifications & Licensure

MA State Medical License 2017 - 2026
ME State Medical License 2020 - 2021
American Board of Internal Medicine Medical Oncology

Clinical Trials

AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC Start of enrollment: 2024 Aug 08
RECRUITING
PHASE2
Roles: Principal Investigator, Sponsor-Investigator, Contact

Publications & Presentations

PubMed

First Results of Migoprotafib, a Potent and Highly Selective Src Homology-2 Domain-Containing Phosphatase 2 Inhibitor in Patients with Advanced Solid Tumors.
Melissa L Johnson, Beni B Wolf, Judy S Wang, Alexander Philipovskiy, Geoffrey I Shapiro
Molecular Cancer Therapeutics. 2025-03-04
A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial.
Francesca Sarno, Jair Tenorio, Sofia Perea, Laura Medina, Roberto Pazo-Cid
Clinical Cancer Research. 2025-01-17
A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer.
Brandon M Huffman, Osama E Rahma, Kevin Tyan, Yvonne Y Li, Anita Giobbie-Hurder
Cancer Immunology Research. 2025-01-09

Press Mentions

Agenus (AGEN) Q1 2023 Earnings Call TranscriptMay 9th, 2023
Novel Strategies Show Winning Potential in Ovarian CancerMarch 28th, 2023
Agenus’ Botensilimab in Combination with Balstilimab Shows 33% Durable Responses in Ovarian CancerMarch 27th, 2023
Join now to see all